385 related articles for article (PubMed ID: 34117356)
21. Extranodal natural killer/T-cell lymphoma: advances in the management.
Jaccard A; Hermine O
Curr Opin Oncol; 2011 Sep; 23(5):429-35. PubMed ID: 21743325
[TBL] [Abstract][Full Text] [Related]
22. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma.
Li YX; Liu QF; Fang H; Qi SN; Wang H; Wang WH; Song YW; Lu J; Jin J; Wang SL; Liu YP; Lu N; Liu XF; Yu ZH
Clin Cancer Res; 2009 Apr; 15(8):2905-12. PubMed ID: 19318493
[TBL] [Abstract][Full Text] [Related]
23. How we treat NK/T-cell lymphomas.
Tse E; Zhao WL; Xiong J; Kwong YL
J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
[TBL] [Abstract][Full Text] [Related]
24. International analysis of the frequency and outcomes of NK/T-cell lymphomas.
William BM; Armitage JO
Best Pract Res Clin Haematol; 2013 Mar; 26(1):23-32. PubMed ID: 23768638
[TBL] [Abstract][Full Text] [Related]
25. Therapy of peripheral T/NK neoplasms.
Greer JP
Hematology Am Soc Hematol Educ Program; 2006; ():331-7. PubMed ID: 17124080
[TBL] [Abstract][Full Text] [Related]
26. Resistance to Fas-mediated apoptosis is restored by cycloheximide through the downregulation of cellular FLIPL in NK/T-cell lymphoma.
Jeon YK; Kim H; Park SO; Choi HY; Kim YA; Park SS; Kim JE; Kim YN; Kim CW
Lab Invest; 2005 Jul; 85(7):874-84. PubMed ID: 15924153
[TBL] [Abstract][Full Text] [Related]
27. T/NK cell type chronic active Epstein-Barr virus disease in adults: an underlying condition for Epstein-Barr virus-associated T/NK-cell lymphoma.
Isobe Y; Aritaka N; Setoguchi Y; Ito Y; Kimura H; Hamano Y; Sugimoto K; Komatsu N
J Clin Pathol; 2012 Mar; 65(3):278-82. PubMed ID: 22247563
[TBL] [Abstract][Full Text] [Related]
28. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of natural killer-cell malignancies.
Ishida F; Kwong YL
Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
[TBL] [Abstract][Full Text] [Related]
30. Comparison of primary and secondary cutaneous CD56+ NK/T cell lymphomas.
Chang SE; Yoon GS; Huh J; Choi JH; Sung KJ; Moon KC; Koh JK
Appl Immunohistochem Mol Morphol; 2002 Jun; 10(2):163-70. PubMed ID: 12051636
[TBL] [Abstract][Full Text] [Related]
31. [Advances of treatment for extranodal NK/T-cell lymphoma --- review].
Zhang SS; Wei M; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):1075-8. PubMed ID: 21867647
[TBL] [Abstract][Full Text] [Related]
32. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
[TBL] [Abstract][Full Text] [Related]
33. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
Liang R
Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
[TBL] [Abstract][Full Text] [Related]
34. Novel targets for natural killer/T-cell lymphoma immunotherapy.
Kumai T; Kobayashi H; Harabuchi Y
Immunotherapy; 2016; 8(1):45-55. PubMed ID: 26642249
[TBL] [Abstract][Full Text] [Related]
35. Peripheral T cell lymphoma of the nasopharynx with expansion of EBV-positive B cells masquerading as an extranodal NK/T cell lymphoma, nasal type.
Kim HN; Kim DS; Jeon MJ; Yu ES; Choi CW; Ko YH
Virchows Arch; 2022 Jul; 481(1):125-129. PubMed ID: 34997312
[TBL] [Abstract][Full Text] [Related]
36. Primary cutaneous NK/T-cell lymphoma, nasal type and CD56-positive peripheral T-cell lymphoma: a cellular lineage and clinicopathologic study of 60 patients from Asia.
Takata K; Hong ME; Sitthinamsuwan P; Loong F; Tan SY; Liau JY; Hsieh PP; Ng SB; Yang SF; Pongpruttipan T; Sukpanichnant S; Kwong YL; Hyeh Ko Y; Cho YT; Chng WJ; Matsushita T; Yoshino T; Chuang SS
Am J Surg Pathol; 2015 Jan; 39(1):1-12. PubMed ID: 25188863
[TBL] [Abstract][Full Text] [Related]
37. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
Yamaguchi M; Suzuki R; Oguchi M
Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
[TBL] [Abstract][Full Text] [Related]
38. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
[TBL] [Abstract][Full Text] [Related]
39. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas.
Stuver R; Epstein-Peterson ZD; Horwitz SM
Haematologica; 2023 Dec; 108(12):3244-3260. PubMed ID: 38037801
[TBL] [Abstract][Full Text] [Related]
40. [Nasal and pharyngeal non-Hodgkin lymphomas and their relationship with Epstein-Barr virus: a report of 158 cases].
He YJ; Jia XS; Hasui K; Wang EH; He AG
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):94-7. PubMed ID: 17493382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]